Multiple lines of evidence show that the higher the degree of HSD11B2 promoter methylation, the lower the activity of 11β-HSD2, which possibly explains the inconsistent phenotype of hypertension among AME patients (9, 89). Here, HSD11B2 is linked to Hypertension.